pc 버전으로 이동 중 [시장보고서]세계의 DNases, 리가아제, RNA 중합효소 시장 규모, 점유율, 동향 분석 리포트 : 응용별(DNases : 바이오의약품 가공, Ligases : 올리고뉴클레오티드 합성), 지역별, 부문별 예측(2022-2030년)
세계의 DNases, 리가아제, RNA 중합효소 시장 규모, 점유율, 동향 분석 리포트 : 응용별(DNases : 바이오의약품 가공, Ligases : 올리고뉴클레오티드 합성), 지역별, 부문별 예측(2022-2030년)
DNases, Ligases, And RNA Polymerases Market Size, Share & Trends Analysis Report By Application (DNases - Biopharmaceutical Processing, Ligases - Oligonucleotide Synthesis), By Region, And Segment Forecasts, 2022 - 2030
상품코드 : 1147462
리서치사 : Grand View Research, Inc.
발행일 : 2022년 10월
페이지 정보 : 영문 142 Pages
US $ 5,950 ₩ 7,404,000
Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,648,000
Printable PDF (5-User License)
US $ 8,950 ₩ 11,137,000
Printable PDF (Enterprise License)


한글목차

Grand View Research, Inc.의 새로운 보고서에 따르면 세계의 DNases, 리가아제, RNA 중합효소 시장 규모는 2030년까지 12억 8,000만 달러에 이를 것으로 예측됩니다. 2022년부터 2030년까지는 연평균 복합 성장률(CAGR) 8.58%로 확대될 것으로 예측됩니다. 연구개발비 증가는 시장 성장을 가속하는 주요 요인 중 하나입니다. DNA 관련 혁신에 대한 주목과 함께, 바이오의약품 생산이 증가하고 있는 것 또한 예측 기간에 세계의 DNases 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 DNases 시장 : 응용 비즈니스 분석

제4장 DNases 시장 : 경쟁 구도 환경

제5장 리가아제 시장 : 응용 비즈니스 분석

제6장 리가아제 시장 경쟁 구도 환경

제7장 RNA 중합효소 시장 : 응용 비즈니스 분석

제8장 RNA 중합효소 시장 : 경쟁 구도

제9장 DNases, 리가아제, RNA 중합효소 시장 : 지역 비즈니스 분석

LSH 22.11.17
영문 목차

영문목차

DNases, Ligases, And RNA Polymerases Market Growth & Trends:

The global DNases, ligases, and RNA polymerases market size is expected to reach USD 1.28 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.58% from 2022 to 2030. Increasing research and development expenditure is one of the key factors fueling market growth. Furthermore, rising biopharmaceutical production along with a focus on DNA-related innovations is expected to positively impact the global DNases market growth over the forecast period.

For instance, in June 2020, Alphazyme and Codexis entered into a strategic partnership to provide novel enzymes for diagnostics and research. DNases have continued to garner a significant market share in recent years owing to factors such as an increase in the adoption of DNA enzymes related to pharmaceuticals, which are essential for the treatment of various chronic disorders and digestive diseases. In addition, developments in the biotechnology and pharmaceutical fields, such as the introduction of genetic and protein engineering, have helped in expanding applications of enzymes, which is expected to offer lucrative growth opportunities in the forecast period.

An increase in R&D investments to develop ligases as the target for therapeutic applications in cancer is estimated to drive the segment in the forecast period. In addition, strategic activities by major manufacturers will offer lucrative growth opportunities in the projected period. Other factors augmenting segment growth include advancements in healthcare, increasing demand for modernization in the field of medical academics and life sciences, growing investments by governments to develop genomic technologies, and a surge in the demand for oligonucleotide synthesis by private and public research firms.

The COVID-19 pandemic situation has offered lucrative opportunities for RNA polymerase applications. Currently, there are over 150 vaccines and therapeutics that either use mRNA in their production processes or are based on mRNA molecules, which are being assessed for the treatment of a wide range of indications. Many mRNA vaccines are approved for emergency use in many countries across the globe.

For instance, Moderna's mRNA-1273 and BioNTech/ Pfizer BNT-162 vaccines have been approved for use across various regions globally. Moreover, there are instances of huge capital investments for the development of mRNA vaccines. For instance, in June 2021, Sanofi declared an investment of around USD 452.12 annually for its mRNA vaccines development center.

DNases, Ligases, And RNA Polymerases Market Report Highlights:

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 DNases Market: Application Business Analysis

Chapter 4 DNases Market: Competitive Landscape

Chapter 5 Ligases Market: Application Business Analysis

Chapter 6 Ligases Market Competitive Landscape

Chapter 7 RNA Polymerases Market: Application Business Analysis

Chapter 8 RNA Polymerases Market: Competitive Landscape

Chapter 9 DNases, Ligases, RNA Polymerases Market: Regional Business Analysis

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기